Alendronic acid

Also known as: Alendronate sodium

Active ingredient description

Alendronic acid is a bisphosphonate that inhibits osteoclastic bone resorption with no direct effect on bone formation. The bone formed during treatment with alendronic acid is of normal quality.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Alendronic acid
M Musculo-skeletal system → M05 Drugs for treatment of bone diseases → M05B Drugs affecting bone structure and mineralization → M05BA Bisphosphonates
Discover more medicines within M05BA04

Medicines

Alendronic acid is the active ingredient of these drugs:

Drug
Countries

Spain

South Africa

Hong Kong

Brazil

Hong Kong

Poland

New Zealand

Hong Kong

Poland

Italy

Italy

Hong Kong South Africa

Italy

Hong Kong

Cyprus Finland Germany Ireland Singapore

Brazil

Brazil

France Ireland Netherlands

Brazil

South Africa

Tunisia

Australia South Africa

Italy

Brazil

South Africa

Australia

South Africa

Tunisia

Austria Brazil Canada France Germany

South Africa

Ireland

Italy

South Africa

Italy

Brazil

Cyprus

Singapore

Italy

Brazil

Hong Kong

South Africa

Italy

Italy

Austria

Brazil

Lithuania Poland

Brazil

Poland

Brazil

Brazil

Hong Kong

Austria

Poland

Brazil

Italy

Italy

Hong Kong

Poland

Spain

Spain

France

Germany Hong Kong Ireland

Alendronic acid is also found within below combination drugs:

ADROVANCE , ALENCALCI D3 , BENTEXO , BONENDRO , FONATPLUS , FOSALEN D3 , FOSAMAX D , FOSAMAX PLUS , FOSASTAD , FOSAVANCE , TEBONEVA , TRIDEPOS , VANTAVO

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Summary of Product Characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

3D molecular structure

3D representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

X1J18R4W8P - ALENDRONIC ACID

CAS registry number

121268-17-5 - Alendronate sodium trihydrate

66376-36-1 - alendronic acid

SNOMED-CT

391730008 - Alendronic acid (substance)